The influence of anti-TNF therapy upon incidence of keratinocyte skin cancer in patients with rheumatoid arthritis: Longitudinal results from the British Society for Rheumatology Biologics Register

Louise K. Mercer, Adele C. Green, James B. Galloway, Rebecca Davies, Mark Lunt, William G. Dixon, Kath D. Watson, Deborah P M Symmons, Kimme L. Hyrich, Nicola Maiden, Tom Price, Neil Hopkinson, Sheila O'Reilly, Lesley Hordon, Ian Griffiths, Duncan Porter, Hilary Capell, Andy Hassell, Romela Benitha, Ernest ChoyDavid Walsh, Paul Emery, Susan Knight, Ian Bruce, Allister Taggart, David Scott, Paul Thompson, Fiona McCrae, Rhian Goodfellow, George Kitas, Ronald Jubb, Rikki Abernethy, Shane Clarke, Sandra Green, Paul Sanders, Amanda Coulson, Bev Harrison, Marwan Bukhari, Peter Klimiuk

Division of Musculoskeletal & Dermatological Sciences (L5)

Research output: Contribution to journal › Article › peer-review

1 results
- Title(descending)

Biologics registers for immune-mediated inflammatory diseases: enhancing access to novel therapies and balancing drug safety concerns versus effectiveness
Hyrich, K. (Participant), Bruce, I. (Participant), Griffiths, C. (Participant), Warren, R. (Participant), Symmons, D. (Participant), Ashcroft, D. (Participant), Dixon, W. (Participant), Lunt, M. (Participant), Yiu, Z. (Participant) & (Participant)
Impact: Health and wellbeing

The influence of anti-TNF therapy upon incidence of keratinocyte skin cancer in patients with rheumatoid arthritis: Longitudinal results from the British Society for Rheumatology Biologics Register

Impacts

Search results

Biologics registers for immune-mediated inflammatory diseases: enhancing access to novel therapies and balancing drug safety concerns versus effectiveness